KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash from Financing Activities (2016 - 2025)

Exact Sciences has reported Cash from Financing Activities over the past 16 years, most recently at -$75.9 million for Q4 2025.

  • Quarterly Cash from Financing Activities fell 822.67% to -$75.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$338.1 million through Dec 2025, down 245.81% year-over-year, with the annual reading at -$338.1 million for FY2025, 245.81% down from the prior year.
  • Cash from Financing Activities was -$75.9 million for Q4 2025 at Exact Sciences, down from -$1.5 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $224.6 million in Q2 2024 and troughed at -$256.2 million in Q1 2025.
  • The 5-year median for Cash from Financing Activities is $1.5 million (2022), against an average of $6.9 million.
  • Year-over-year, Cash from Financing Activities skyrocketed 4784.68% in 2023 and then crashed 8433.34% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$12.2 million in 2021, then soared by 182.84% to $10.1 million in 2022, then fell by 0.65% to $10.0 million in 2023, then grew by 4.6% to $10.5 million in 2024, then plummeted by 822.67% to -$75.9 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Cash from Financing Activities are -$75.9 million (Q4 2025), -$1.5 million (Q3 2025), and -$4.5 million (Q2 2025).